Detall de la convocatòria


Objectiu de la convocatòria
Postdoctoral Fellowships for a period of up to three years to support excellent postdoctoral researchers in laboratories throughout Europe.
Característiques principals
The goals of the programme are:
  • to support the career development of outstanding EACR early career members.
  • to train the next generation of scientists engaged in innovative research in areas where AstraZeneca has demonstrated leadership through its pipeline and research programs.
  • to build research collaborations between the EACR, institutions and AstraZeneca in core therapeutic areas to support development of the pipeline.

    Proposed research projects must:
  • be basic and/or translational in nature
  • have direct applicability and relevance to at least one of breast, bladder, lung, prostate, ovarian or paediatric cancer.

    Projects should focus on one of the following research areas:
  • Cell Therapy
  • Immunotherapy
  • Tumour drivers and resistance
  • Mechanisms of sensitivity / resistance to PARP inhibitors and other DNA
  • Damage Response inhibitors
  • Mechanisms of sensitivity and resistance to antibody drug conjugates
  • Epigenetics
  • Haematology

    Measures of success:
  • High impact publications describing innovative additions to the field
  • Short and long-term satisfaction with the programme
  • Career development of Fellows
  • Continued academic interactions with the fellow and / or academic supervisors and AstraZeneca
  • Lloc de presentació
    IMIM and PSMAR staff who need more information should contact::
    Competitive Funding. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: [email protected] Ext.: 1670
    Marta López: [email protected] Ext.: 1576
    Convocatòria (URL)
  • You must be an EACR Early Career Member at the submission deadline.
  • If your EACR membership is through one of the EACR’s associated National Societies. you are eligible if you match the requirements of the Early Career membership categories.
  • You must work actively and currently in cancer research, for example in academia, in industry or as a clinician or physician scientist.
  • You must have had at least one first (or joint first) author primary research paper published in an international peer reviewed journal at the time of application. Papers must be published in English. Abstracts of presentations at conferences and review articles should not be listed as publications. Publication updates once the selection process has started are not allowed.
  • You must be based at a European academic institution for the duration of the Fellowship, with the potential to arrange a placement at an AstraZeneca site by mutual agreement of both AstraZeneca and the academic
  • Supervisors. This means that you must have the agreement of the host institution to employ you according to the terms of the Fellowship, if you are not already employed at that institution. You note that you will be responsible for any costs associated with a placement or visit to AstraZeneca, including travel and accommodation.
  • Dotació
    The salary of the awardee (the mid-point postdoctoral researcher salary at the host institution or €70,000, whichever is lower), the employer’s costs and a 25% overhead fee to be used at the employer’s discretion.
    3 years